Reuters cited IPOX® Associate Lukas Muehlbauer on Holtec’s suspended U.S. IPO, linking the company’s investment case to expectations for higher electricity demand from data centres amid the AI boom. Muehlbauer said the broader IPO pipeline should remain active without widespread postponements, while noting investor concerns around AI development, interest rates, and weak nuclear-sector performance. “The underlying demand for energy has not disappeared, but investors are becoming more selective about how much they are willing to pay today for future growth.”

IPOX® Associate Lukas Muehlbauer commented on Altera’s planned U.S. IPO, highlighting investor focus on the chipmaker’s exposure to hyperscalers and AI infrastructure demand. Reuters reported that Altera, backed by Silver Lake and Intel, has confidentially filed to go public and could raise more than $2 billion. Muehlbauer noted that whether hyperscalers remain a material part of Altera’s customer base will be an important consideration for investors once the company’s public filing becomes available.

IPOX® VP Kat Liu said in Reuters coverage that SPAC mergers can provide a more flexible route for defense and space companies with government contracts, strategic backing or clear growth pipelines that lack the revenue scale or predictability required for traditional IPOs. Reuters reports six defense and space-related companies have announced SPAC mergers in 2026, double the total in 2025, as investor appetite surges. The sector is also benefiting from rising government spending and strong demand for satellite, defense and aerospace technologies this year.

IPOX® VP Kat Liu said insurance companies’ recurring revenue and resilient demand are attractive in volatile markets as Reuters covered CVC-backed Bamboo Insurance’s planned U.S. IPO. Bamboo is targeting a valuation of up to $3.24 billion, with selling shareholders seeking as much as $700 million. Liu also noted that Bamboo’s managing general underwriter model creates dependence on insurance carriers and capacity providers. The company plans to list on the NYSE under the ticker “BMB” amid relatively strong insurance IPO performance.

IPOX® Associate Lukas Muehlbauer commented on the fall IPO market as Holtec Nuclear targets a valuation of up to $10.2 billion in its U.S. IPO. He said early deals could set the tone for the broader market, with strong debuts potentially encouraging more listings and weak pricing or aftermarket performance narrowing the window. Muehlbauer added that economic fundamentals, market conditions and the Federal Reserve’s September meeting are likely to drive IPO activity, with limited impact from midterm elections this year.